文献速递肝病炎症性肠病

回肠储袋肛管吻合术对原发性硬化性胆管炎肝移植后移植物生存的影响

The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis.
PubMed 文献 · Aliment Pharmacol Ther · 2018-06-08

该研究基于1990至2016年前瞻性肝移植数据库,纳入240例原发性硬化性胆管炎合并结肠炎行肝移植患者,其中75例需结肠切除术。回肠储袋肛管吻合术(IPAA)组移植物丢失发生率高于末端回肠造口组(2.8 vs 0.4/100患者年,P=0.005),IPAA组与未行结肠切除组无显著差异(2.8 vs 1.7,P=0.1)。结论:IPAA与未行结肠切除相比肝动脉血栓、复发性胆道狭窄和再移植发生率相似,末端回肠造口带来更有利的移植物结局。

要点

  • IPAA组移植物丢失发生率2.8/100患者年,高于末端回肠造口组的0.4/100患者年(P=0.005)。
  • IPAA组与未行结肠切除组移植物丢失率无显著差异(2.8 vs 1.7/100患者年,P=0.1)。
  • 末端回肠造口组移植物丢失率显著低于保留完整结肠组(P=0.044)。

核心结论

  • 在原发性硬化性胆管炎中,肝移植后结肠切除加IPAA与未行结肠切除相比,肝动脉血栓、复发性胆道狭窄和再移植的发生率相似。
  • 结肠切除加末端回肠造口带来更有利的移植物结局。

研究设计与样本

  • 前瞻性收集的移植数据库研究,评估移植物生存,按结肠切除状态和类型分层。
  • 1990年至2016年间,240例原发性硬化性胆管炎合并结肠炎患者接受移植(累计1870患者年至首次移植物丢失或末次随访日期),其中75例还需结肠切除。

主要发现

  • IPAA组移植物丢失发生率高于保留末端回肠造口组(2.8 vs 0.4/100患者年,log-rank P=0.005)。
  • IPAA组与未行结肠切除组移植物丢失率无显著差异(2.8 vs 1.7/100患者年,P=0.1)。
  • 末端回肠造口组移植物丢失率显著低于保留完整结肠组(P=0.044)。
  • 经时间依赖Cox回归分析考虑结肠切除与肝移植的时间关系后,IPAA带来的风险持续存在。
  • 肝动脉血栓和胆道狭窄是移植物丢失的主要病因;IPAA组与未行结肠切除组两者发生率无显著差异(P=0.092和P=0.358),而末端回肠造口似乎有保护作用(P=0.007和0.031)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Liver transplantation is the only life-extending intervention for primary sclerosing cholangitis (PSC). Given the co-existence with colitis, patients may also require colectomy; a factor potentially conferring improved post-transplant outcomes. AIM: To determine the impact of restorative surgery via ileal pouch-anal anastomosis (IPAA) vs retaining an end ileostomy on liver-related outcomes post-transplantation. METHODS: Graft survival was evaluated across a prospectively accrued transplant database, stratified according to colectomy status and type. RESULTS: Between 1990 and 2016, 240 individuals with PSC/colitis underwent transplantation (cumulative 1870 patient-years until first graft loss or last follow-up date), of whom 75 also required colectomy. A heightened incidence of graft loss was observed for the IPAA group vs those retaining an end ileostomy (2.8 vs 0.4 per 100 patient-years, log-rank P = 0.005), whereas rates between IPAA vs no colectomy groups were not significantly different (2.8 vs 1.7, P = 0.1). In addition, the ileostomy group experienced significantly lower graft loss rates vs. patients retaining an intact colon (P = 0.044). The risks conferred by IPAA persisted when taking into account timing of colectomy as related to liver transplantation via time-dependent Cox regression analysis. Hepatic artery thrombosis and biliary strictures were the principal aetiologies of graft loss overall. Incidence rates for both were not significantly different between IPAA and no colectomy groups (P = 0.092 and P = 0.358); however, end ileostomy appeared protective (P = 0.007 and 0.031, respectively). CONCLUSION: In PSC, liver transplantation, colectomy + IPAA is associated with similar incidence rates of hepatic artery thrombosis, recurrent biliary strictures and re-transplantation compared with no colectomy. Colectomy + end ileostomy confers more favourable graft outcomes.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Trivedi PJ, Reece J, Laing RW, et al. The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2018. PMID: 29882252. doi:10.1111/apt.14828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。